Molecular study of the hematopoietic zinc finger gene in three unrelated families with gray platelet syndrome

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 9, 2005, Pages 2077-2080

  Bénit, Laurence ^a,c   Cramer, E M ^a   Masse J M ^a   Dusanter Fourt, I ^a   Favier, R ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSTITUT COCHIN   (France)

Author keywords

Gray platelet syndrome; Hematopoietic zinc finger gene; Platelets

Indexed keywords

ZINC FINGER PROTEIN;

ARTICLE; BLEEDING DISORDER; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FAMILY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PRIORITY JOURNAL;

BLOOD PLATELET DISORDERS; CASE-CONTROL STUDIES; EXONS; FAMILY HEALTH; HUMANS; MEGAKARYOCYTES; POLYMORPHISM, GENETIC; RNA, MESSENGER; ZINC FINGERS;

EID: 30644459483     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01524.x     Document Type: Article

References (12)

1. Raccuglia G. Gray platelet syndrome: a variety of qualitative platelet disorders. Am J Med 1971; 51: 818-28.
2. Rosa JP, George JN, Bainton DF, Nurden AT, Caen JP, McEver RP. Gray platelet syndrome: demonstration of α-granule membranes that can fuse with the cell surface. J Clin Invest 1987; 80: 1138-46.
3. Kimura Y, Hart A, Hirashima M, Wang C, Holmyard D, Pittman J, Pang XL, Jackson CW, Bersntein A. Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis. J Exp Med 2002; 195: 941-52.
4. Hidaka M, Caruana G, Stanford WL, Sam M, Correll PH, Bernstein A. Gene trapping of two novel genes, Hzf and Hhl, expressed in hematopoietic cells. Mech Dev 2000; 90: 3-15.
5. Fichelson S, Freyssinier JM, Picard F, Fontenay-Roupie M, Guesnu M, Cherai M, Gisselbrecht S, Porteu F. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Blood 1999; 94: 1601-13.
6. Drouin A, Favier R, Masseα JM, Debili N, Schmitt A, Elbim C, Guichard J, Adam M, Gougerot-Pocidalo MA, Cramer EM. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001; 98: 1382-91.
7. Chedani H, Dupuy E, Masseα JM, Cramer EM. Neutrophil secretory defect in the gray platelet syndrome: a new case. Platelets (in press).
8. Cramer EM, Vainchenker W, Vinci G, Guichard J, Breton-Gorius J. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood 1985, 66: 1309-16.
9. Raslova H, Komura E, Le Coueαdic JP, Larbret F, Debili N, Feunteun J, Danos O, Albagli O, Vainchenker W, Favier R. FLII monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest 2004; 114: 77-84.
10. Schmitt A, Guichard J. Masse JM, Debili N, Cramer EM. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp Hematol 2001; 29: 1295-302.
11. Smyth SS, Tsakiris DA, Scudder LE, Coller BS. Structure and function of murine alphaIIb/beta3 (GPIIb/IIIa): studies using monoclonal antibodies and beta3-null mice. Thromb Haemost 2000; 84: 1103-8.
12. Knoch KP, Bergert H, Borgonovo B, Saeger HD, Altkrüger A, Verkade P, Solimena M. Polypyrimidine tract-binding protein promotes insulin secretory granule biogenesis. Nat Cell Biol 2004; 6: 207-14.